- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Axcan Pharma
Total 8295 results
-
Evoke PharmaCompletedDiabetes Mellitus | Diabetes | Gastroparesis | Delayed Gastric Emptying | Diabetic GastroparesisUnited States
-
Edmond PharmaUnknownChronic Obstructive Pulmonary Disease (COPD)Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
-
AM-PharmaWithdrawnBacteremia | Staphylococcal InfectionsNetherlands
-
Vifor PharmaCompletedChronic Kidney DiseaseUnited States, Switzerland, Romania, Croatia, Bulgaria, Germany, Czech Republic, Poland, Russian Federation
-
UCB PharmaCompletedRheumatoid ArthritisDenmark, Netherlands, Poland, Sweden
-
LEO PharmaCompleted
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
UCB PharmaCompletedSeasonal Allergic Rhinitis
-
UCB PharmaCompletedRhinitis, Allergic, SeasonalCanada
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
UCB PharmaCompletedNeuralgia, Postherpetic
-
LEO PharmaCompletedRenal ImpairmentCanada
-
LEO PharmaCompleted
-
LEO PharmaCompleted
-
LEO PharmaCompletedAtopic DermatitisNetherlands
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
UCB PharmaCompletedGeneralized Convulsive Epilepsy
-
Clavis PharmaCompletedOvarian CancerBelgium, Italy
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
UCB PharmaCompleted
-
Clavis PharmaCompletedNot Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy SubjectsUnited Kingdom
-
Advanz PharmaWithdrawn
-
UCB PharmaCompleted
-
Kiadis PharmaCompletedHematologic Diseases | Hematologic MalignanciesCanada
-
HRA PharmaCompletedEmergency ContraceptionSweden, Netherlands, United Kingdom
-
LEO PharmaTerminatedAtopic DermatitisGermany
-
Psyadon PharmaCompletedLesch-Nyhan DiseaseUnited States
-
UCB PharmaCompletedEpilepsy, PartialUnited States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
-
UCB PharmaCompletedImmune System Diseases | Autoimmune Diseases | Lupus Erythematosus, Systemic | Skin and Connective Tissue Diseases | Connective Tissue DiseaseBelgium, Bulgaria, Germany
-
UCB PharmaCompleted
-
UCB PharmaCompletedPeptic UlcerFrance, Poland, Spain, Belgium, Greece, Hungary
-
UCB PharmaCompletedHealthy SubjectsUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
UCB PharmaTerminatedLupus Erythematosus, SystemicUnited States
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, Belgium, Netherlands, United Kingdom, Spain, Hungary
-
UCB PharmaCompletedDermatitis | EczemaKorea, Republic of
-
UCB PharmaCompletedChronic Idiopathic UrticariaFrance, Germany, United Kingdom, Belgium, Spain, Malaysia, Romania, South Africa, Italy
-
UCB PharmaCompletedParkinson's DiseaseGermany, Austria, United Kingdom
-
Otic PharmaCompletedOtorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | OtitisIsrael
-
Clavis PharmaCompletedSolid TumorsNetherlands, Belgium
-
UCB PharmaCompleted
-
Clavis PharmaCompletedColorectal Cancer | Advanced Colorectal CancerUnited Kingdom
-
Advanz PharmaCompletedAtrial FibrillationNetherlands, United States, Canada, Denmark
-
AM-PharmaCompletedBacterial Infections and Mycoses | Hematopoietic Stem Cell TransplantationNetherlands
-
Dafra PharmaCompletedMulti-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum MalariaPlasmodium Falciparum MalariaCameroon, Mali, Rwanda, Sudan